CSGP vs PHAT · P/E 484, rev $2.74B vs rev $55.3M
CoStar Group Inc (CSGP) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the CSGP and PHAT stock pages for the full models.
Not investment advice.